-+ 0.00%
-+ 0.00%
-+ 0.00%
On the evening of October 9, Shandong Wohua Pharmaceutical Technology Co., Ltd. disclosed the 2026 three-quarter report, becoming the first A-share listed company to disclose the three-quarter report this year. As the disclosure of the third quarterly report begins, the performance of listed companies is expected to become a hot topic in the market. In response, institutions generally believe that the market performance of the company's stock price in October was clearly positively correlated with the growth rate of its three-quarter report. Performance verification may become the main line of the market, and capital is shifting from “overfall repair” to “performance verification.” In this context, the three-quarter report market is expected to become the main line of longing leading the rebound.
Share
Listen to the news
On the evening of October 9, Shandong Wohua Pharmaceutical Technology Co., Ltd. disclosed the 2026 three-quarter report, becoming the first A-share listed company to disclose the three-quarter report this year. As the disclosure of the third quarterly report begins, the performance of listed companies is expected to become a hot topic in the market. In response, institutions generally believe that the market performance of the company's stock price in October was clearly positively correlated with the growth rate of its three-quarter report. Performance verification may become the main line of the market, and capital is shifting from “overfall repair” to “performance verification.” In this context, the three-quarter report market is expected to become the main line of longing leading the rebound.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending